The Only Monthly Membership With a Positive ROI!
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The Only Monthly Membership With a Positive ROI!
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
David Windley
Jefferies Turns Bullish On Molina, Sees Potential For Upside To Estimates
Humana, Anthem Benefit From 'Attractive' Managed Care Sector, Jefferies Says
The INC Research Pullback Creates A Compelling Entry Point
Humana, Anthem Benefit From 'Attractive' Managed Care Sector, Jefferies Says
The INC Research Pullback Creates A Compelling Entry Point
Jefferies Highlights A Pair Trade In Pharma: Buy ICON, Hold Tight On INC Research
Winners And Losers Amid Affordable Care Act Uncertainty
Jefferies Highlights A Pair Trade In Pharma: Buy ICON, Hold Tight On INC Research
Winners And Losers Amid Affordable Care Act Uncertainty
'Full Potential' For UnitedHealth
A Look At 4 Scenarios For Humana In The Wake Of Trump's Election Win
Read More...
David Windley Recent News
Jefferies Downgrades ICON To Hold, Cites Lower Bookings, Sales
Looking Past M&A: The Best Managed Care Stock Plays For The Long Haul
How The Street Is Reacting To The Aetna-Humana Deal
Jefferies Boosts Targets Across Pharmaceutical Service Stocks
UPDATE: Jefferies Reiterates On Humana Inc As Management Displays Confidence
Jefferies Analyst Names Favorites In Managed Healthcare Sector
UPDATE: Jefferies Raises PT on WuXi PharmaTech Following Raised 2013 EPS Guidance
UPDATE: Jefferies Raises PT on PAREXEL Following Solid 2Q Results
UPDATE: Jefferies Raises PT on WellCare Health Plans Following Stock Surge
UPDATE: Jefferies Raises PT on UnitedHealth Group Ahead of 2Q Earnings Report
UPDATE: Jefferies Raises PT on Humana Ahead of 2Q Earnings Report
UPDATE: Jefferies Raises PT on Cigna Ahead of 2Q Earnings Report
UPDATE: Jefferies Raises PT on Aetna Ahead of 2Q Earnings Report
UPDATE: Jefferies Raises PT on WellPoint Ahead of 2Q Earnings Report
UPDATE: Jefferies Raises PT on PAREXEL on Tough Margin Outlook, Premium Valuation
UPDATE: Jefferies Raises PT on Centene Following Exit Delay Announcement
UPDATE: Jefferies Initiates Quintiles Transnational at Hold on Valuation
UPDATE: Jefferies Raises PT on Aetna Following Coventry Acquisition
Jefferies Rates Pharmaceutical Product Development ( PPDI) A Buy
Jefferies & Company, Inc. Upgrades Warner Chilcott Ltd. (WCRX) To Buy Rating
ICON (ICLR) Maintains A Buy Rating